White-C

White-C Special Precautions

filgrastim

Manufacturer:

Shandong Kexing

Distributor:

Goodfellow
Full Prescribing Info
Special Precautions
Patients with premalignant or malignant myeloid conditions. Full blood counts including differential white cell and platelet counts should be monitored. Treatment should be withdrawn in patients who develop signs of pulmonary infiltration. Splenic rupture following administration of granulocyte-colony stimulating factors has been reported; monitor spleen size.
Be cautious in using White-C to patients suffering from myeloid proliferation (eg, acute leukemia).
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in